<?xml version="1.0" encoding="UTF-8"?>
<ref id="B108">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Marchais-Oberwinkler</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Henn</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Möller</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Klein</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Negri</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Oster</surname>
    <given-names>A.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2011</year>). 
  <article-title>17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development</article-title>. 
  <source>J. Steroid Biochem. Mol. Biol.</source>
  <volume>125</volume>, 
  <fpage>66</fpage>–
  <lpage>82</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.jsbmb.2010.12.013</pub-id>
  <pub-id pub-id-type="pmid">21193039</pub-id>
 </mixed-citation>
</ref>
